Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Yen

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Human Mutation|October 9, 2007
An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing lossMichel Guipponi, Min-Yen Toh, Justin Tan, et al.
Nature Communications|July 1, 2015
PPL2ab neurons restore sexual responses in aged Drosophila males through dopamineShu-Yun Kuo, Chia-Lin Wu, Min-Yen Hsieh, et al.
Ophthalmology|May 3, 2026
NSAID use and the risk of AMD: Insights From a Multi-Center Cohort AnalysisAlan Y Hsu, Hou-Ting Kuo, De-Yi Liu, et al.
Biomedicine|April 3, 2025
Mini-review of clinical data service platforms in the era of artificial intelligence: A case study of the iHi data platformYu-Ting Lin, Ya-Chi Lin, Hung-Lin Chen, et al.
Nature Communications|February 9, 2021
Incorporation of sensing modalities into de novo designed fluorescence-activating proteinsJason C Klima, Lindsey A Doyle, Justin Daho Lee, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood Cancer Journal|March 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus ClassificationWan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Human Mutation|October 9, 2007
An integrated genetic and functional analysis of the role of type II transmembrane serine proteases (TMPRSSs) in hearing lossMichel Guipponi, Min-Yen Toh, Justin Tan, et al.
Nature Communications|July 1, 2015
PPL2ab neurons restore sexual responses in aged Drosophila males through dopamineShu-Yun Kuo, Chia-Lin Wu, Min-Yen Hsieh, et al.
Ophthalmology|May 3, 2026
NSAID use and the risk of AMD: Insights From a Multi-Center Cohort AnalysisAlan Y Hsu, Hou-Ting Kuo, De-Yi Liu, et al.
Biomedicine|April 3, 2025
Mini-review of clinical data service platforms in the era of artificial intelligence: A case study of the iHi data platformYu-Ting Lin, Ya-Chi Lin, Hung-Lin Chen, et al.
Nature Communications|February 9, 2021
Incorporation of sensing modalities into de novo designed fluorescence-activating proteinsJason C Klima, Lindsey A Doyle, Justin Daho Lee, et al.
Blood Cancer Journal|January 4, 2023
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AMLXavier Cheng-Hong Tsai, Kuo-Jui Sun, Min-Yen Lo, et al.
Annals of Hematology|November 12, 2021
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experienceYu-Wen Wang, Xavier Cheng-Hong Tsai, Hsin-An Hou, et al.
Blood Cancer Journal|August 9, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classificationWan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, et al.
Blood Cancer Journal|March 13, 2026
Prognostic implications of genetic and transcriptomic abnormalities in MDS according to IPSS-R, IPSS-M, and the International Consensus ClassificationWan-Hsuan Lee, Hsin-An Hou, Chien-Chin Lin, et al.
Blood Cancer Journal|April 9, 2024
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasmsWan-Hsuan Lee, Chien-Chin Lin, Cheng-Hong Tsai, et al.
Pageof 20